Irreversible PulpitisEarly Phase 1NCT07388862
Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent Teeth
A Early Phase 1 study testing Dental operating microscope in people with Irreversible Pulpitis, run by Chulalongkorn University.
Trial summary
The goal of this [randomized clinical trial] is to evaluate the treatment outcome by assessing clinical and radiographic outcomes. The main question it aims to answer is Do using dental operating microscope incorperated with pulpotomy procedure will have a different outcome when compare with without using. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Irreversible Pulpitis
- What is being tested?
- Dental operating microscope
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- 21 Feb 2026to 31 Dec 2037
- Phase
- Early Phase 1
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Healthy patients aged at least 18 years old with deep or extremely deep carious lesions in mature permanent teeth diagnose with asymptomatic or symptomatic irreversible pulpitis. Diagnoses are confirmed using EPT and cold tests. Pulpal and periapical diagnoses are based on terminology from the American Association of Endodontists (AAE, 2013)20.
- Teeth are restorable with direct composite restoration.
Who cannot join
- Teeth with subgingival caries and/or clinical attachment loss more than 3 mm and probing depth more than 4 mm.
- Negative responses to pulp sensibility tests, presence of sinus tracts, swelling, non-restorable crowns, immature roots, or no pulp exposure following complete caries removal in case of pre-operative diagnosis as asymptomatic irreversible pulpitis.
- Patients with systemic diseases involving bleeding disorders such as hemophilia, Von Willebrand disease, platelet disorders. And patients under taking all kind of anticoagulant and anti-platelet.
- Teeth with pulpal obliteration.
- Necrotic pulp is found after access opening
- Bleed cannot be stopped within 8 minutes after full pulpotomy
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent Teeth : A Randomized Controlled Trial
The goal of this [randomized clinical trial] is to evaluate the treatment outcome by assessing clinical and radiographic outcomes.
The main question it aims to answer is
Do using dental operating microscope incorperated with pulpotomy procedure will have a different outcome when compare with without using.
Participants will be asked to have clinical and radiographic evaluation for evaluating the outcome every year after treatment.
Read the detailed description
Materials and methods Study design and setting This study is a prospective, single-center, single-blinded, parallel-group, randomized controlled trial conducted at the Dental Department, Phaholponpayuhasena Hospital. All clinical procedures are performed by a single experienced endodontist. Clinical outcome evaluations are carried out by the same operator, while radiographic outcome evaluations are conducted by another experienced endodontist.
Study participants Inclusion Criteria
- Healthy patients aged at least 18 years old with deep or extremely deep carious lesions in mature permanent teeth diagnose with asymptomatic or symptomatic irreversible pulpitis. Diagnoses are confirmed using EPT and cold tests. Pulpal and periapical diagnoses are based on terminology from the American Association of Endodontists (AAE, 2013)20.
- Teeth are restorable with direct composite restoration. Exclusion Criteria
- Teeth with subgingival caries and/or clinical attachment loss more than 3 mm and probing depth more than 4 mm.
- Negative responses to pulp sensibility tests, presence of sinus tracts, swelling, non-restorable crowns, immature roots, or no pulp exposure following complete caries removal in case of pre-operative diagnosis as asymptomatic irreversible pulpitis.
- Patients with systemic diseases involving bleeding disorders such as hemophilia, Von Willebrand disease, platelet disorders. And patients under taking all kind of anticoagulant and anti-platelet.
- Teeth with pulpal obliteration.
- Necrotic pulp is found after access opening
- Bleed cannot be stopped within 8 minutes after full pulpotomy21,22
Treatment procedure A comprehensive medical and dental history is taken before treatment. Preoperative data, including age, sex, tooth number are recorded in a predesigned patient's chart. The treatment, the study design, alternative treatment modalities, potential benefits, risks, and follow-up protocol are explained to the qualifying patients and informed consent is obtained from the voluntary patients who are willing to participate in the study.
Sample size calculation The sample size calculation is based on a suspected difference of 39.2% in the success rate between the control and magnification group in MB2 orifice finding using n4Studies with a 5% α error. The minimum sample size was calculated to be 46. Considering patients lost to follow-up, a total of 50 teeth from different patients are included in this study.
Randomization and masking Block randomization with variable 4 block sizes is used to generate a sequence of random numbers for allocating the patients equally into two study groups. Each random blocks are sealed in an opaque envelope which is opened at the beginning of the clinical trial by the operator. New block will be open after all the patient in the previous block was completed and repeat until the end of the clinical trials to ensure the equality of group distribution: The vital pulp therapy with and without magnification intervention groups.
Intervention All the treatment is carried out by a single operator. All the patients received a topical anesthesia before local anesthesia. An inferior alveolar nerve block (1.8 ml 2% Lidocaine with epinephrine 1:100,000)+buccal infiltration (1.7 ml 4% Articaine with epinephrine 1:100,000) for mandibular teeth, buccal infiltration (1.8 ml 2% Lidocaine with epinephrine 1:100,000) for maxillary teeth. The anesthesia is confirmed by negative response to EPT. The pulpotomy procedure is performed under rubber dam isolation in a single visit. If the patient experienced pain during the procedure, an additional anesthesia is used to achieve profound pulpal anesthesia by intraligament injection with 0.3 ml 2% Lidocaine with epinephrine 1:100,000. The operating field is disinfected with iodine and alcohol. A cylindrical diamond airotor operates under air water coolant to outline the cavity. Low speed round bur and a spoon excavator are used to remove the soft carious dentine using nonselective caries removal from the periphery towards the centre of the carious lesion. The deepest layer of carious dentine is thereafter disinfected with 2 ml of 2.5% NaOCl prior to pulpal exposure.
The patient will have his or her eyes covered with a dental drape and randomly divided into the following two groups:
Group I (Magnification) : The remaining procedures will be carried on under Zeiss OPMI Pico dental operating microscope (Carl Zeiss Meditec, Germany) with total magnification ranging from 3.6× to 6.0×. More aspects will be included in this group which included:
- If the remaining resected pulp is avascular with necrotic or yellowish liquefied areas, or microscopic hemostasis cannot be achieved, then further tissue removal is attempted
- Ensure the absence of dentin chips and blood clotting above remaining pulp tissue.
- Complete removal of detached pulp tissue and dentine fragments into a vascular pulp.
Group II (Control) : The remaining procedures will be carried on under naked eye.
The new high-speed sterile diamond airotor is used to completely remove the coronal pulp tissue. Then direct passive irrigation with of 2.5% NaOCl solution up to 8 minutes to arrest the bleeding. The time to achieve hemostasis is recorded in minutes and seconds. The diagnosis of vital inflamed pulp is confirmed by the presence of bleeding in the pulp chamber.
In both study groups, 1 mm calcium silicate cement putty type (Totalfil-ERRM) is placed as a caping agent over the residual pulp.The tooth is restored with Resin Modified Glass Ionomer Cement (RMGIC) base (Vitrebond, 3M) and composite restoration (Z350XT, 3M) and polishing in the same visit.
The full pulpotomy cases where bleeding from residual pulp cannot be arrested within 8 minutes, are excluded from the study, and pulpectomyare performed. Immediate post-operative periapical radiograph is taken.
Treatment outcome assessment All the teeth are assessed clinically at 6 months and every year and radiographs are taken. Clinically asymptomatic teeth without any radiographic evidence of periapical rarefaction or root resorption are categorized as success in strict criteria and categorized as survival in loose criteria when clinically asymptomatic teeth with periapical rarefaction.
Recall Clinical evaluation and periapical radiograph will be taken. The quality of the coronal restoration is checked, and the restorations are repaired if deemed necessary. In case of failed cased, the cause of failure will be identified and recorded. Proper treatment will be proposed for specific problem.
Clinical evaluation included
- Coronal restoration
- EPT
- Percussion
- Palpation
- Mobility
- Probing depth
- Occlusion All clinical evaluation will be evaluated by the same operator who was blinded from the intervention.
Radiographic evaluation included
- Periapical radiograph The same operator will judge the quality of the recall radiograph which include
- 3x3 mm area covered the periapical area
- No distortion or blurred
- The image is able to interpret the periapical tissue
The blinded experienced endodontist will be evaluate the radiographic success of recall radiograph by recording as:
- Normal periapical tissue
- Thickening PDL space
- Periapical lesion
Statistical analysis The Kolmogorov-Smirnov test is used to assess the normality of continuous data. Fisher's exact test analyze demographic variables. The dichotomous outcome of success versus failure will be used as the dependent variable to statistically analyze the prognostic factors. The impact of prognostic factors on treatment outcomes will be statistically analyzed using bivariate and multivariate multilevel logistic regression. Success rates between groups are analyzed using the t-test. A p-value of < 0.05 is considered statistically significant.
- Conditions
- Irreversible Pulpitis
- Being tested
- Dental operating microscope
- Keywords
- Pulpotomy, treatment outcome, dental operating microscope
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dental operating microscopeDevice
Incorperating the using of dental operating microscope into the pulpotomy procedure
| Study group | Role | What they receive |
|---|---|---|
| Additional using of dental operating microscope in the procedure | Experimental | using of dental operating microscope (OPMI PICO, Carl Zeiss) in the procedure for improving the quality of treatment Receives: Device: Dental operating microscope |
| Routine pulpotomy | No intervention | Routine pulpotomy procedure without addition using of dental operating microscope |
What is being measured
The primary outcome is the main question the study is designed to answer.
Treatment outcome
Treatment outcomes will be classified as healed, healing, or failure based on clinical and radiographic evaluations.
Healed: Cases presenting with no clinical symptoms and no evidence of a periapical lesion on radiographic examination.
Healing: Cases presenting with no clinical symptoms and a reduction in the size of the periapical lesion on radiographic examination.
Failure: Cases presenting with clinical symptoms and/or enlargement of the periapical lesion on radiographic examination.
Measured: Yearly up to 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Feb 2026
- Study start21 Feb 2026 (estimated)
- Primary completion31 Dec 2036 (estimated)
- Study completion31 Dec 2037 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Irreversible PulpitisStudies of the same condition, open and under way.
- More trials run by Chulalongkorn UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Early Phase 1
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chulalongkorn University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sirawut Hiran-us, Chulalongkorn University
- Investigators
- Sirawut Hiran-us, Study director, Faculty of Dentistry, Chulalongkorn UniversityChoontawee Soponsakulkaew, Principal investigator, Phaholponpayuhasena Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07388862
- Sponsor's protocol ID
- BBC 28/2025
- Status last verified
- Jan 2026
- First submitted
- 21 Jan 2026
- Last updated
- 18 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 18 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent Teeth : A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07388862
- Acronym / sponsor ID
- BBC 28/2025
- Conditions
- Irreversible Pulpitis
- Keywords
- Pulpotomy, treatment outcome, dental operating microscope
- Phase
- Early Phase 1
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Chulalongkorn UniversityUniversity, hospital or other
- Study start
- 21 Feb 2026 (estimated)
- Primary completion
- 31 Dec 2036 (estimated)
- Study completion
- 31 Dec 2037 (estimated)
- First posted
- 5 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this [randomized clinical trial] is to evaluate the treatment outcome by assessing clinical and radiographic outcomes.
The main question it aims to answer is
Do using dental operating microscope incorperated with pulpotomy procedure will have a different outcome when compare with without using.
Participants will be asked to have clinical and radiographic evaluation for evaluating the outcome every year after treatment.
Detailed description
Materials and methods Study design and setting This study is a prospective, single-center, single-blinded, parallel-group, randomized controlled trial conducted at the Dental Department, Phaholponpayuhasena Hospital. All clinical procedures are performed by a single experienced endodontist. Clinical outcome evaluations are carried out by the same operator, while radiographic outcome evaluations are conducted by another experienced endodontist.
Study participants Inclusion Criteria
- Healthy patients aged at least 18 years old with deep or extremely deep carious lesions in mature permanent teeth diagnose with asymptomatic or symptomatic irreversible pulpitis. Diagnoses are confirmed using EPT and cold tests. Pulpal and periapical diagnoses are based on terminology from the American Association of Endodontists (AAE, 2013)20.
- Teeth are restorable with direct composite restoration. Exclusion Criteria
- Teeth with subgingival caries and/or clinical attachment loss more than 3 mm and probing depth more than 4 mm.
- Negative responses to pulp sensibility tests, presence of sinus tracts, swelling, non-restorable crowns, immature roots, or no pulp exposure following complete caries removal in case of pre-operative diagnosis as asymptomatic irreversible pulpitis.
- Patients with systemic diseases involving bleeding disorders such as hemophilia, Von Willebrand disease, platelet disorders. And patients under taking all kind of anticoagulant and anti-platelet.
- Teeth with pulpal obliteration.
- Necrotic pulp is found after access opening
- Bleed cannot be stopped within 8 minutes after full pulpotomy21,22
Treatment procedure A comprehensive medical and dental history is taken before treatment. Preoperative data, including age, sex, tooth number are recorded in a predesigned patient's chart. The treatment, the study design, alternative treatment modalities, potential benefits, risks, and follow-up protocol are explained to the qualifying patients and informed consent is obtained from the voluntary patients who are willing to participate in the study.
Sample size calculation The sample size calculation is based on a suspected difference of 39.2% in the success rate between the control and magnification group in MB2 orifice finding using n4Studies with a 5% α error. The minimum sample size was calculated to be 46. Considering patients lost to follow-up, a total of 50 teeth from different patients are included in this study.
Randomization and masking Block randomization with variable 4 block sizes is used to generate a sequence of random numbers for allocating the patients equally into two study groups. Each random blocks are sealed in an opaque envelope which is opened at the beginning of the clinical trial by the operator. New block will be open after all the patient in the previous block was completed and repeat until the end of the clinical trials to ensure the equality of group distribution: The vital pulp therapy with and without magnification intervention groups.
Intervention All the treatment is carried out by a single operator. All the patients received a topical anesthesia before local anesthesia. An inferior alveolar nerve block (1.8 ml 2% Lidocaine with epinephrine 1:100,000)+buccal infiltration (1.7 ml 4% Articaine with epinephrine 1:100,000) for mandibular teeth, buccal infiltration (1.8 ml 2% Lidocaine with epinephrine 1:100,000) for maxillary teeth. The anesthesia is confirmed by negative response to EPT. The pulpotomy procedure is performed under rubber dam isolation in a single visit. If the patient experienced pain during the procedure, an additional anesthesia is used to achieve profound pulpal anesthesia by intraligament injection with 0.3 ml 2% Lidocaine with epinephrine 1:100,000. The operating field is disinfected with iodine and alcohol. A cylindrical diamond airotor operates under air water coolant to outline the cavity. Low speed round bur and a spoon excavator are used to remove the soft carious dentine using nonselective caries removal from the periphery towards the centre of the carious lesion. The deepest layer of carious dentine is thereafter disinfected with 2 ml of 2.5% NaOCl prior to pulpal exposure.
The patient will have his or her eyes covered with a dental drape and randomly divided into the following two groups:
Group I (Magnification) : The remaining procedures will be carried on under Zeiss OPMI Pico dental operating microscope (Carl Zeiss Meditec, Germany) with total magnification ranging from 3.6× to 6.0×. More aspects will be included in this group which included:
- If the remaining resected pulp is avascular with necrotic or yellowish liquefied areas, or microscopic hemostasis cannot be achieved, then further tissue removal is attempted
- Ensure the absence of dentin chips and blood clotting above remaining pulp tissue.
- Complete removal of detached pulp tissue and dentine fragments into a vascular pulp.
Group II (Control) : The remaining procedures will be carried on under naked eye.
The new high-speed sterile diamond airotor is used to completely remove the coronal pulp tissue. Then direct passive irrigation with of 2.5% NaOCl solution up to 8 minutes to arrest the bleeding. The time to achieve hemostasis is recorded in minutes and seconds. The diagnosis of vital inflamed pulp is confirmed by the presence of bleeding in the pulp chamber.
In both study groups, 1 mm calcium silicate cement putty type (Totalfil-ERRM) is placed as a caping agent over the residual pulp.The tooth is restored with Resin Modified Glass Ionomer Cement (RMGIC) base (Vitrebond, 3M) and composite restoration (Z350XT, 3M) and polishing in the same visit.
The full pulpotomy cases where bleeding from residual pulp cannot be arrested within 8 minutes, are excluded from the study, and pulpectomyare performed. Immediate post-operative periapical radiograph is taken.
Treatment outcome assessment All the teeth are assessed clinically at 6 months and every year and radiographs are taken. Clinically asymptomatic teeth without any radiographic evidence of periapical rarefaction or root resorption are categorized as success in strict criteria and categorized as survival in loose criteria when clinically asymptomatic teeth with periapical rarefaction.
Recall Clinical evaluation and periapical radiograph will be taken. The quality of the coronal restoration is checked, and the restorations are repaired if deemed necessary. In case of failed cased, the cause of failure will be identified and recorded. Proper treatment will be proposed for specific problem.
Clinical evaluation included
- Coronal restoration
- EPT
- Percussion
- Palpation
- Mobility
- Probing depth
- Occlusion All clinical evaluation will be evaluated by the same operator who was blinded from the intervention.
Radiographic evaluation included
- Periapical radiograph The same operator will judge the quality of the recall radiograph which include
- 3x3 mm area covered the periapical area
- No distortion or blurred
- The image is able to interpret the periapical tissue
The blinded experienced endodontist will be evaluate the radiographic success of recall radiograph by recording as:
- Normal periapical tissue
- Thickening PDL space
- Periapical lesion
Statistical analysis The Kolmogorov-Smirnov test is used to assess the normality of continuous data. Fisher's exact test analyze demographic variables. The dichotomous outcome of success versus failure will be used as the dependent variable to statistically analyze the prognostic factors. The impact of prognostic factors on treatment outcomes will be statistically analyzed using bivariate and multivariate multilevel logistic regression. Success rates between groups are analyzed using the t-test. A p-value of < 0.05 is considered statistically significant.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Additional using of dental operating microscope in the procedure | Experimental | Device: Dental operating microscopeusing of dental operating microscope (OPMI PICO, Carl Zeiss) in the procedure for improving the quality of treatment |
| Routine pulpotomy | No intervention | –Routine pulpotomy procedure without addition using of dental operating microscope |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Healthy patients aged at least 18 years old with deep or extremely deep carious lesions in mature permanent teeth diagnose with asymptomatic or symptomatic irreversible pulpitis. Diagnoses are confirmed using EPT and cold tests. Pulpal and periapical diagnoses are based on terminology from the American Association of Endodontists (AAE, 2013)20.
- Teeth are restorable with direct composite restoration.
Key exclusion criteria (6 listed)
- Teeth with subgingival caries and/or clinical attachment loss more than 3 mm and probing depth more than 4 mm.
- Negative responses to pulp sensibility tests, presence of sinus tracts, swelling, non-restorable crowns, immature roots, or no pulp exposure following complete caries removal in case of pre-operative diagnosis as asymptomatic irreversible pulpitis.
- Patients with systemic diseases involving bleeding disorders such as hemophilia, Von Willebrand disease, platelet disorders. And patients under taking all kind of anticoagulant and anti-platelet.
- Teeth with pulpal obliteration.
- Necrotic pulp is found after access opening
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dental operating microscopeIncorperating the using of dental operating microscope into the pulpotomy procedure | Device | Additional using of dental operating microscope in the procedure |
Primary outcome
Treatment outcome
Time frame: Yearly up to 10 years
Treatment outcomes will be classified as healed, healing, or failure based on clinical and radiographic evaluations. Healed: Cases presenting with no clinical symptoms and no evidence of a periapical lesion on radiographic examination. Healing: Cases presenting with no clinical symptoms and a reduction in the size of the periapical lesion on radiographic examination. Failure: Cases presenting with clinical symptoms and/or enlargement of the periapical lesion on radiographic examination.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Mar 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Irreversible Pulpitis
Recruiting
Effect of Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite on Post-Operative Endodontic Pain.
Symptomatic Irreversible Pulpitis, Symptomatic Apical Periodontitis
Not yet recruiting
Post-operative Pain and Clinical Outcome After Single-cone Obturation With a Calcium Silicate-based Versus Epoxy Resin Sealer
Post Operative Pain, Acute, Irreversible Pulpitis (Toothache)
Not yet recruitingPhase 3
Submucosal Cryotherapy and Anti-inflammatory Drugs for Postoperative Pain Following Root Canal Treatment in Maxillary Molars
Pulpitis
Recruiting
Intraligamentary vs Inferior Alveolar Nerve Block for Pulpitis: A Randomized Clinical Trial
Symptomatic Irreversible Pulpitis (SIP), Dental Pain
Not yet recruitingPhase 4
Cost-Effectiveness of Upfront Supplemental Anaesthesia in Symptomatic Irreversible Pulpitis
Irreversible Pulpitis, Anesthesia, Local
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Sirawut Hiran-us study director
Faculty of Dentistry, Chulalongkorn University
Choontawee Soponsakulkaew principal investigator
Phaholponpayuhasena Hospital
Questions about this trial
What is this clinical trial studying?
A Early Phase 1 study testing Dental operating microscope in people with Irreversible Pulpitis, run by Chulalongkorn University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sirawut Hiran-us, DDS, MSc, High Grad Dip, FRCDS (66 812055775, sirawut.h@chula.ac.th), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Treatment outcome (time frame: Yearly up to 10 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.